Company Revenue

The company's orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds....

The company grew in the high-teens in the third quarter of 2024, as its wide-ranging portfolio insulated it from market...

The company grew in the mid-single digits, driven by its broad product portfolio and increasing U.S. market penetration....

The company grew in the mid-single digits on a pro forma basis in the third quarter of 2024 as it...

The company grew 63% on a reported basis in the third quarter of 2024 as it anniversaried its merger with...

The company's orthopedic sales grew in the mid-single digits but headwinds in China will have an ongoing impact into 2025....

The company declined in the mid-single digits during the third quarter of 2024 as it pivots away from Arthrosurface and...

The company grew more than 27% in the third quarter of 2024 as it hones its focus on attaining cash...

The company grew in the mid-single digits in the third quarter of 2024 as it worked through ERP-related issues impacting...

The company's orthopedic sales grew nearly 5% in the third quarter of 2024 but hurricane impacts will impact fourth quarter...